FMC lands $400M investment from Belgium's Tessenderlo to cut debt
What's the deal? FMC CorporationDealroom has a profile for this one. Try Dealroom →, a global agricultural sciences company, has agreed to a roughly $400 million minority equity investment from Belgian industrial group Tessenderlo Group.
The deal, announced June 30, 2026, prices shares at $13.30 and hands Tessenderlo about 20% of FMC's outstanding stock.
FMC plans to use the cash to hit its target of paying down approximately $1 billion in debt.
Why now? The investment concludes FMC's review of strategic options, launched in February 2026.
It caps months of moves to shore up its balance sheet, including a $1.2 billion high-yield bond offering, a $252 million sale of its India business, and a $200 million prepayment tied to a supply deal with CortevaDealroom has a profile for this one. Try Dealroom →.
"This agreement follows a comprehensive and deliberate process," said Pierre Brondeau, FMC's chairman, chief executive officer, and president.
What could go wrong? The deal still needs regulatory approvals and other customary conditions before closing.
FMC's turnaround also hinges on execution: advancing its R&D pipeline and commercialising new proprietary molecules as an independent company.
The signal: Tessenderlo's roughly 20% stake in mature agricultural sciences player FMC underscores how corporate investors are using cornerstone minority positions to build out agro platforms rather than pursuing outright acquisitions. The bet reflects a wider push in the sector, where a new generation of proprietary molecules is reshaping competitive positions and drawing fresh capital.
Image credit: aqua.mech
